Sign in
XENT Stock Price, Chart, Stats & News
Intersect ENT, Inc.
Save
Intersect ENT, Inc. (XENT) does not currently pay a dividend.
–
Market cap
–
Current P/E
–
Forward P/E
XENT chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 71.89% |
Operating margin | -145.10% |
Pretax margin | -151.13% |
Net margin | -149.54% |
Effective tax rate | 1.05% |
ROA | -108.69% |
ROE | 15521.15% |
D/E | -2.06x |
Interest coverage ratio | -24.06x |
XENT valuation
P/E | – |
P/S | – |
P/B | -13.60x |
P/CF | -15.80x |
P/FCF | – |
P/OCF | -15.80x |
PEG | -0.06x |
EV multiple | 0.69x |
About
Intersect ENT, Inc. is a medical technology firm focused on ear, nose, and throat (ENT) solutions, operating within the United States. Its product portfolio includes: PROPEL, PROPEL Mini, and PROPEL Contour: These are steroid-eluting implants. PROPEL is designed to maintain the patency of surgically enlarged sinuses, while PROPEL Mini targets patients undergoing frontal sinus procedures.
Similar securities
Based on sector and market capitalization
Report issue